U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C7H9N3.2ClH
Molecular Weight 208.088
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of 4-AMIDINOANILINE DIHYDROCHLORIDE

SMILES

Cl.Cl.NC(=N)C1=CC=C(N)C=C1

InChI

InChIKey=GHEHNICLPWTXJC-UHFFFAOYSA-N
InChI=1S/C7H9N3.2ClH/c8-6-3-1-5(2-4-6)7(9)10;;/h1-4H,8H2,(H3,9,10);2*1H

HIDE SMILES / InChI

Approval Year

PubMed

PubMed

TitleDatePubMed
Natural and synthetic inhibitors of kallikrein-related peptidases (KLKs).
2010-11
dsDNA-triggered energy transfer and lanthanide sensitization processes. Luminescent probing of specific A/T sequences.
2010-08-14
Trypsin-like serine proteases in Lutzomyia longipalpis--expression, activity and possible modulation by Leishmania infantum chagasi.
2010-05-18
Conversion of trypsin to a copper enzyme: tyrosinase/catechol oxidase by chemical modification.
2010
Molecular basis of thrombomodulin activation of slow thrombin.
2009-10
Purification and partial characterization of a myofibril-bound serine protease from ostrich skeletal muscle.
2009-10
Activation loop 3 and the 170 loop interact in the active conformation of coagulation factor VIIa.
2009-06
An earthworm protease cleaving serum fibronectin and decreasing HBeAg in HepG2.2.15 cells.
2008-11-24
Functional role of residue 193 (chymotrypsin numbering) in serine proteases: influence of side chain length and beta-branching on the catalytic activity of blood coagulation factor XIa.
2008-02-05
Neutralization of plasminogen activator inhibitor I (PAI-1) by the synthetic antagonist PAI-749 via a dual mechanism of action.
2007-10
Macromolecular substrate-binding exosites on both the heavy and light chains of factor XIa mediate the formation of the Michaelis complex required for factor IX-activation.
2007-08-28
Cell surface-bound plasminogen regulates hepatocyte proliferation through a uPA-dependent mechanism.
2007-06
Novel biomimetic affinity ligands for human tissue plasminogen activator.
2007-04-13
A cross-reactive material positive variant of coagulation factor XI (FXIP520L) with a catalytic defect.
2007-04
Eisenia fetida protease-III-1 functions in both fibrinolysis and fibrogenesis.
2007
Biological fingerprinting analysis of the interactome of a kinase inhibitor in human plasma by a chemiproteomic approach.
2006-11-17
Superparamagnetic poly(methyl methacrylate) beads for nattokinase purification from fermentation broth.
2006-09
High resolution structures of p-aminobenzamidine- and benzamidine-VIIa/soluble tissue factor: unpredicted conformation of the 192-193 peptide bond and mapping of Ca2+, Mg2+, Na+, and Zn2+ sites in factor VIIa.
2006-08-25
Recovery of urokinase from integrated mammalian cell culture cryogel bioreactor and purification of the enzyme using p-aminobenzamidine affinity chromatography.
2006-06-09
Amplification of the urokinase gene and the sensitivity of prostate cancer cells to urokinase inhibitors.
2006-02
A urokinase-type plasminogen activator-inhibiting cyclic peptide with an unusual P2 residue and an extended protease binding surface demonstrates new modalities for enzyme inhibition.
2005-11-18
Shedding of the germinal angiotensin I-converting enzyme (gACE) involves a serine protease and is activated by epididymal fluid.
2005-11
Mutagenesis studies toward understanding the mechanism of the cofactor function of thrombomodulin.
2005-10-03
Na+ site in blood coagulation factor IXa: effect on catalysis and factor VIIIa binding.
2005-07-01
Exosite-mediated substrate recognition of factor IX by factor XIa. The factor XIa heavy chain is required for initial recognition of factor IX.
2005-06-24
Quantitative determination of the ligand content in Benzamidine Sepharose 4 Fast Flow media with ion-pair chromatography.
2005-04-08
Degradation of berenil (diminazene aceturate) in acidic aqueous solution.
2004-10
Structural role of Gly(193) in serine proteases: investigations of a G555E (GLY193 in chymotrypsin) mutant of blood coagulation factor XI.
2004-07-09
Augmented intrinsic activity of Factor VIIa by replacement of residues 305, 314, 337 and 374: evidence of two unique mutational mechanisms of activity enhancement.
2004-04-15
Zymogenic and enzymatic properties of the 70-80 loop mutants of factor X/Xa.
2004-02
Potent bivalent inhibition of human tryptase-beta by a synthetic inhibitor.
2003-12
Characterization of p-aminobenzamidine-based sorbent and its use for high-performance affinity chromatography of trypsin-like proteases.
2003-08-15
Increased migration of murine keratinocytes under hypoxia is mediated by induction of urokinase plasminogen activator.
2002-12
Clonidine displacement from type 1 imidazoline receptor by p-aminobenzamidine, the prototype of trypsin-like serine protease inhibitors.
2002-11
Thermodynamic linkage between the S1 site, the Na+ site, and the Ca2+ site in the protease domain of human activated protein C (APC). Sodium ion in the APC crystal structure is coordinated to four carbonyl groups from two separate loops.
2002-08-09
4-Aminoarylguanidine and 4-aminobenzamidine derivatives as potent and selective urokinase-type plasminogen activator inhibitors.
2002-08-05
Kinetic analysis of a unique direct prothrombinase, fgl2, and identification of a serine residue critical for the prothrombinase activity.
2002-05-15
The catalytic domain of endogenous urokinase-type plasminogen activator is required for the mitogenic activity of platelet-derived and basic fibroblast growth factors in human vascular smooth muscle cells.
2002-05-01
Inhibition of urokinase-type plasminogen activator delays expression of c-jun, activated transforming growth factor beta 1, and matrix metalloproteinase 2 during post-hepatectomy liver regeneration in mice.
2002-05
A functional comparison of ovine and porcine trypsins.
2002-03
Purification and characterization of an extracellular trypsin-like protease of Fusarium oxysporum var. lini.
2002
Linear competitive inhibition of human tissue kallikrein by 4-aminobenzamidine and benzamidine and linear mixed inhibition by 4-nitroaniline and aniline.
2001-01
Inhibition of pig liver and Zea mays L. polyamine oxidase: a comparative study.
2001
[Synthetic inhibitors of serine proteinases. Part 26: Inhibition of trypsin, plasmin and thrombin by amides of N alpha-arylsulfonylated 2-amino-4-(4-amidino-phenyl) butyric acid and 2-amino-5-amidinophenyl valeric acids (author's transl)].
1982-04
Patents
Name Type Language
BENZAMIDINE, P-AMINO-, DIHYDROCHLORIDE
Preferred Name English
4-AMIDINOANILINE DIHYDROCHLORIDE
Systematic Name English
4-AMINOBENZAMIDINE DIHYDROCHLORIDE
Systematic Name English
P-AMINOBENZAMIDINE DIHYDROCHLORIDE
Common Name English
BENZENECARBOXIMIDAMIDE, 4-AMINO-, HYDROCHLORIDE (1:2)
Systematic Name English
BENZENECARBOXIMIDAMIDE, 4-AMINO-, DIHYDROCHLORIDE
Systematic Name English
NSC-56418
Code English
Code System Code Type Description
EPA CompTox
DTXSID10179695
Created by admin on Mon Mar 31 20:38:44 GMT 2025 , Edited by admin on Mon Mar 31 20:38:44 GMT 2025
PRIMARY
ECHA (EC/EINECS)
219-692-2
Created by admin on Mon Mar 31 20:38:44 GMT 2025 , Edited by admin on Mon Mar 31 20:38:44 GMT 2025
PRIMARY
FDA UNII
3C7VNU62AG
Created by admin on Mon Mar 31 20:38:44 GMT 2025 , Edited by admin on Mon Mar 31 20:38:44 GMT 2025
PRIMARY
NSC
56418
Created by admin on Mon Mar 31 20:38:44 GMT 2025 , Edited by admin on Mon Mar 31 20:38:44 GMT 2025
PRIMARY
PUBCHEM
75626
Created by admin on Mon Mar 31 20:38:44 GMT 2025 , Edited by admin on Mon Mar 31 20:38:44 GMT 2025
PRIMARY
CAS
2498-50-2
Created by admin on Mon Mar 31 20:38:44 GMT 2025 , Edited by admin on Mon Mar 31 20:38:44 GMT 2025
PRIMARY